We postulate that this myocardial fibrosis is likely to be a pre-existing risk factor for severe disease courses of COVID-19, whereby increased expression of sIL1-RL1 induces NRP-1 expression that facilitates ACE2-mediated SARS-CoV-2 entry into the lung. This evidence concerns the gene ACE2 and COVID-19.